Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell’s Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Mitchell
Article
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
Workers' Comp
Article
A Shot in the Arm to Move Claims Forward During COVID
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
Mitchell
Article
As Crises Linger, U.S. Hospitals Continue to Face Headwinds
This article is authored by guest blogger, Jill Harris, Senior Director, Network Development at Coventry, a part of Mitchell | Genex | Coventry
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q4 2020
The quarterly LOR summary is produced by
Mitchell
Article
COVID—A Year Later
How the World (May Be) Forever Changed by COVID-19 One year ago this week, our Company sent out the first set of employee notices to adop